Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Bristol-Myers Squibb halts Hep C pill study

August 2, 2012 Research and Development, Sales and Marketing BMS, hepatitis C, pill, trial suspension

Bristol-Myers Squibb has halted a mid-stage trial of a new Hepatitis C drug due to major safety concerns. In a …
News

Government to harness NHS patient data for research use

August 2, 2012 Sales and Marketing NHS, R&D, UK, david cameron, innovation, real world data

The UK government will change the NHS Constitution in order to allow patients’ data to be used for research purposes. …
News

New UK drug pricing system will ‘stifle innovation’

August 2, 2012 Sales and Marketing ABPI, PPRS, UK government, VBP

The ABPI has attacked the UK government’s new drug pricing policy, saying it will not benefit the pharma industry. Value-Based …
News

Daiichi Sankyo: breaking down barriers with social media

August 1, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chatter, Daiichi Sankyo, NHS, social media

Digital media is known to help create interaction and dialogue between groups and organisations, but new technology can also create …
Feature

Olympics to kick-start research ventures

August 1, 2012 Research and Development, Sales and Marketing GSK, London 2012, Olympics, research

London 2012 could provide a boost in the continuing search for personalised medicines for diabetes, heart disease and dementia as …
News

Pfizer’s RA pill impresses in Phase III

August 1, 2012 Research and Development, Sales and Marketing FDA, JAK, Pfizer, RA

Pfizer’s investigational arthritis drug tofacitinib has beaten methotrexate in a head-to-head study. Tofacitinib, an oral Janus kinase (JAK) inhibitor, is …
News

Lipitor loss continues to hit Pfizer sales

July 31, 2012 Sales and Marketing Enbrel, Lipitor, Pfizer, Prevnar, Q2

Pfizer has posted a loss in revenue for the second quarter as the firm continues to feel the impact of …
News

Dendreon slashes staff and closes facility

July 31, 2012 Manufacturing and Production, Sales and Marketing Dendreon, M&P, Provenge, prostate cancer

Cancer vaccine specialist Dendreon has said it will slash 600 jobs and close one of its three manufacturing facilities in …
News

Ariad files new blood cancer drug with the FDA

July 31, 2012 Research and Development, Sales and Marketing Ariad, CML, EMA, FDA, Glivec, blood cancer

Ariad has filed its investigational blood cancer drug ponatinib with the FDA and hopes for an accelerated review. The US …
News

Soren Tulstrup to lead Shire’s genetics franchise

July 31, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Shire has appointed Soren Tulstrup as its new senior vice president and franchise lead, MPS (mucopolysaccharides) for its human genetic …
Appointment

Bayer raises guidance after strong sales

July 31, 2012 Sales and Marketing Bayer, Nexavar, Q2, Xarelto, Yasmin

The Bayer Group has raised its full-year guidance for 2012 following positive results in the second quarter. This is despite …
News

Fitch to pharma: don’t expect 2012 to be a bumper year

July 31, 2012 Sales and Marketing 2012, FDA approvals, Fitch, IMS Health, NMEs, ratings

The Fitch ratings agency has published pessimistic projections for pharma, saying that it should not expect as many US drug …
News

Merck sees growth in second quarter

July 30, 2012 Sales and Marketing Cozaar, Merck, Q2, Singulair

Merck has posted a healthy sales increase for the second quarter, as its established drugs grew strongly. Sales increased 1% …
News

Parkinson’s specialist spins out from Merck Serono’s Swiss R&D ops

July 30, 2012 Research and Development, Sales and Marketing Merck Serono, Parkinson's, Prexton, Swiss

A company specialising in novel treatments for Parkinson’s disease is the first to be spun out of Merck Serono’s soon-to-close …
News

Bayer guilty of multiple Code breaches

July 30, 2012 Medical Communications, Sales and Marketing ABPI Code, Bayer, Xarelto, breach, clause

Bayer Healthcare has admitted to 12 breaches of the ABPI Code after one of its staff developed and distributed drug …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026